Prophylactic ECMO Support during Elective Coronary Percutaneous Interventions in High-Risk Patients: A Single-Center Experience.
Claudiu Mihnea UngureanuMarc BlaimontHugues TrinePierre HeninRomain CourcelleYves LaurentPatrick Van RuysseveltCaroline LepièceVincent HuberlantPublished in: Journal of interventional cardiology (2023)
Prophylactic use of VA-ECMO in elective patients is an acceptable strategy for revascularization by high-risk coronary percutaneous interventions with good long-term outcomes for patients considered inoperable when a clear clinical benefit is expected. Regarding the potential risk of complications due to a VA-ECMO system, the selection of candidates in our series was based on a multiparameter analysis. The two main triggers in favor of prophylactic VA-ECMO in our studies were the presence of a recent heart failure episode and the high probability of periprocedural prolonged impairment of the coronary flow through the major epicardial artery.
Keyphrases
- end stage renal disease
- heart failure
- ejection fraction
- newly diagnosed
- coronary artery disease
- extracorporeal membrane oxygenation
- chronic kidney disease
- coronary artery
- prognostic factors
- physical activity
- minimally invasive
- left ventricular
- squamous cell carcinoma
- aortic stenosis
- respiratory failure
- risk factors
- radiation therapy
- patient reported outcomes
- intensive care unit
- climate change
- atrial fibrillation
- patient reported
- transcatheter aortic valve replacement
- aortic valve
- acute heart failure